Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preliminary results reported for Biojector 2000-delivered malaria vaccine

Dec. 29, 1999

Japanese patent covers BioSante's novel vaccine adjuvant/drug delivery system

Dec. 28, 1999

CV Technologies' ginseng extract enters phase II for respiratory infection prophylaxis

Dec. 27, 1999

Aviron's FluMist protects against influenza infection

Dec. 27, 1999

Oxo Chemie reports promising data for immune therapeutic

Dec. 22, 1999

Synthetic immunogens useful for preparation of HPV preventive vaccine

Dec. 20, 1999

La Jolla presents positive results from animal studies of xenotransplantation drug

Dec. 17, 1999

Vasogen to commence clinical trials of VAS-981 for prevention of GVHD

Dec. 16, 1999

New chikungunya virus vaccine safe and highly immunogenic in humans

Dec. 13, 1999

Recombinant HEV vaccine: safety and immunogenicity in monkeys and humans

Dec. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.